What are the lines and who draws them?: The CRISPR-Cas9 story
By Sara Moretto,
The Varsity
| 09. 22. 2024
It was 2020. I was wrapping up grade nine science with a solid 60 per cent, hoping that if anyone saw my failed tests in the recycling bin, it would contribute to an air of mystery about me. This reason was preferable to the truth, which was that I was sick and I had been for a while. I didn’t like many subjects, least of all science, with its academic rigour and air of superiority. I felt that science was a body of knowledge sealed behind textbooks for those people who were suited to learn. It was for the people who understood pharmacy through reactions; physiology through diagrams; and who are essentially healers armed with multi-coloured highlighters.
In the same year, biochemists Emmanuelle Charpentier and Jennifer Doudna were studying bacterial immune systems. Bacteria defend themselves from invading viruses differently than humans. After an infection, bacteria store chunks of invading viral genetic material within their DNA for later reference, like a molecular ‘Wanted’ poster for future viral attacks. These bacteria store what they learned from the viruses in a section called the clustered...
Related Articles
By Meagan Parrish, PharmaVoice | 10.10.2025
When CEO Ben Lamm steps into the spotlight, it’s usually to talk about his efforts bringing extinct animals back to life. Once a far-flung idea, Lamm and the company he heads, Colossal Biosciences, have proven they can pull it off...
By Daniel Hildebrand, The Humanist | 10.01.2025
When most people hear the word eugenics, they think of dusty history textbooks and black-and-white photographs: forced sterilizations in the early 20th century, pseudoscientific charts measuring skulls, the language of “fitness” used to justify violence and exclusion. It feels like...
By Alondra Nelson, Science | 09.11.2025
In the United States, the summer of 2025 will be remembered as artificial intelligence’s (AI’s) cruel summer—a season when the unheeded risks and dangers of AI became undeniably clear. Recent months have made visible the stakes of the unchecked use...
By Margaux MacColl, The San Francisco Standard | 09.17.2025
Designer babies are coming soon to an IVF clinic near you.
Nucleus Genomics, founded by Kian Sadeghi in 2020, when he was just 20, got its start analyzing genomes to weigh a person’s risk of everything from cancer to ADHD...